化工与医药工程
化工與醫藥工程
화공여의약공정
Chemical and Pharmaceutical Engineering
2015年
5期
41-43
,共3页
丹参%提取浓缩%真空缓冲罐%球型浓缩器%技术改进
丹參%提取濃縮%真空緩遲罐%毬型濃縮器%技術改進
단삼%제취농축%진공완충관%구형농축기%기술개진
salvia miltiorrhiza%extraction and condensation%vacuum tank%spherical condenser%technical improvement
目的:解决复方丹参薄膜衣片中主要活性成份丹参提取液,使用乙醇回收浓缩器不易清洁且有残留,不符合GMP规范要求的问题。改进方法:采用球型浓缩器,加装真空缓冲罐,以每片含量丹参酮ⅡA、丹酚酸B作为主要含量测定指标,对丹参提取液浓缩工艺进行技术改进。结果:丹参酮ⅡA、丹酚酸B含量符合质量标准,球型浓缩罐不残留浸膏、易收膏、易清洁,符合GMP要求。结论:技术改进后,浓缩设备不残留浸膏、易收膏、易清洁,生产中杜绝了污染和交叉污染风险的发生,生产过程符合GMP要求。同时相应提高了浸膏收率,丹参酮ⅡA、丹酚酸B含量在复方丹参薄膜衣片检测项中亦符合质量标准,增加了该产品的经济效益,可用于实际生产。
目的:解決複方丹參薄膜衣片中主要活性成份丹參提取液,使用乙醇迴收濃縮器不易清潔且有殘留,不符閤GMP規範要求的問題。改進方法:採用毬型濃縮器,加裝真空緩遲罐,以每片含量丹參酮ⅡA、丹酚痠B作為主要含量測定指標,對丹參提取液濃縮工藝進行技術改進。結果:丹參酮ⅡA、丹酚痠B含量符閤質量標準,毬型濃縮罐不殘留浸膏、易收膏、易清潔,符閤GMP要求。結論:技術改進後,濃縮設備不殘留浸膏、易收膏、易清潔,生產中杜絕瞭汙染和交扠汙染風險的髮生,生產過程符閤GMP要求。同時相應提高瞭浸膏收率,丹參酮ⅡA、丹酚痠B含量在複方丹參薄膜衣片檢測項中亦符閤質量標準,增加瞭該產品的經濟效益,可用于實際生產。
목적:해결복방단삼박막의편중주요활성성빈단삼제취액,사용을순회수농축기불역청길차유잔류,불부합GMP규범요구적문제。개진방법:채용구형농축기,가장진공완충관,이매편함량단삼동ⅡA、단분산B작위주요함량측정지표,대단삼제취액농축공예진행기술개진。결과:단삼동ⅡA、단분산B함량부합질량표준,구형농축관불잔류침고、역수고、역청길,부합GMP요구。결론:기술개진후,농축설비불잔류침고、역수고、역청길,생산중두절료오염화교차오염풍험적발생,생산과정부합GMP요구。동시상응제고료침고수솔,단삼동ⅡA、단분산B함량재복방단삼박막의편검측항중역부합질량표준,증가료해산품적경제효익,가용우실제생산。
Objective:?to?solve?the?problem?that?in?obtaining?salvia?miltiorrhiza?extraction,?recovery?condenser?is?dififcult?to?be?cleaned?and ethanol may be remained, which is not consistent with the requirements in GMP standard. Improving method:to use spherical condenser and add vacuum buffer tank, with the contents of tanshinone II A and Dan Phenolic acid B in each tablet as measuring index, salvia miltiorrhiza extraction condensing process was technically reformed. Result:tanshinone II A and Dan Phenolic acid B conform to the quality standard. In spherical tank, there is no remained extracts. Liquid is easy be condensed and the equipment is easy be cleaned. Thus, GMP requirements are reached. Conclusion:with technical improvement, there is no remained extracts, the liquid is easy be condensed and the equipment is easy be cleaned. The occurrences of contamination and cross contamination have been avoided. GMP requirements are met in the process of production. At the same time, extract yield increases, the contents of tanshinone II A and Dan Phenolic acid B inspected in salvia miltiorrhiza tablet are also consistent with quality standard. Thus the economic?proift?is?increased?and?this?process?can?be?used?in?practical?production.